55579-90-3

Basic information

• Product Name: 7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one
• Synonyms: 7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one
• CAS NO: 55579-90-3
• Molecular Formula: C₁₀H₉ClO₂
• Molecular Weight: 196.63026
• Mol File: 55579-90-3.mol

Chemical Properties

• Boiling Point: 335 °C at 760 mmHg
• Flash Point: 151 °C
• Appearance: /
• Density: 1.281 g/cm³
• CAS DataBase Reference: 7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one(55579-90-3)
• EPA Substance Registry System: 7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one(55579-90-3)

Safety Data

• Hazardous Substances Data: 55579-90-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one is employed as a key component in the development of new drugs and treatments due to its chemical structure and potential therapeutic effects. It is particularly noted for its potential as an antipsychotic and anxiolytic drug, offering benefits in the treatment of mental health conditions.
Used in Neurological Disorder Treatment:
In the medical field, 7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one is used as a potential treatment for neurological disorders, leveraging its capacity to address underlying conditions and symptoms associated with such disorders.
Used in Anti-inflammatory and Analgesic Applications:
7-Chloro-3,4-dihydro-2H-benzo[b]oxepin-5-one is also utilized in applications requiring anti-inflammatory and analgesic properties, making it a candidate for the management of pain and inflammation in various medical conditions.

Upstream product

• 106-48-9 4-chloro-phenol 
• 3547-07-7 γ-(4-chlorophenoxy)-butyric acid 

Downstream Products

• 1279116-31-2 7-chloro-4-((4-(2-chlorophenyl)piperazin-1-yl)methyl)-3,4-dihydro-benzo[b]oxepin-5(2H)-one 
• 1279116-33-4 4-(4-fluorobenzylidene)-7-chloro-3,4-dihydrobenzo[b]oxepin-5(2H)-one 
• 1279116-34-5 4-(4-chlorobenzylidene)-7-chloro-3,4-dihydrobenzo[b]oxepin-5(2H)-one 
• 1279116-32-3 4-benzylidene-7-chloro-3,4-dihydrobenzo[b]oxepin-5(2H)-one 
• 1279116-35-6 7-chloro-4-(4-methoxybenzylidene)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 
• 1279116-37-8 1-(7-chloro-2,3,4,5-tetrahydro-5-oxobenzo[b]oxepin-4-yl)-5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione 
• 1279116-43-6 2-(4-methoxyphenyl)-4,4',5,6-tetrahydro-1'-chlorobenzo[4',3':2,3]oxepino[4,5-c]pyridazin-3(2H)one 
• 1279116-42-5 2-(4-chlorophenyl)-4,4',5,6-tetrahydro-1'-chlorobenzo[4',3':2,3]oxepino[4,5-c]pyridazin-3(2H)one 
• 1279116-41-4 2-phenyl-4,4',5,6-tetrahydro-1'-chlorobenzo[4',3':2,3]oxepino[4,5-c]pyridazin-3(2H)one 
• 1384168-51-7 C₂₁H₁₄ClN₃O₃ 

Relevant articles and documents

Benzoxepin derivatives: Design, synthesis, and pharmacological evaluation with sedative-hypnotic effect

A series of novel benzoxepin-derived compounds were synthesized and evaluated for their sedative- hypnotic effect using Phenobarbital-induced sleep test in mice. Compound 6 in which the Phenobarbital moiety was incorporated into the benzoxepin nucleus was

A New Class of Antiarrhythmic Agents: Mannich Bases of 3,4-Dihydro-1-benzoxepin-5(2H)-ones and Related Compounds

Mannich bases derived from 3,4-dihydro-1-benzoxepin-5(2H)-ones, chromanones and 6,7,8,9-tetrahydrobenzocyclohepten-5(H)-one have been synthesised and shown to possess marked antiarrhythmic activity; 3,4-dihydro-7-methyl-4-(1-piperidinomethyl)- and 3,4-dih